Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Bladder Cancer

  Free Subscription


Articles published in Urol Int

Retrieve available abstracts of 53 articles:
HTML format



Single Articles


    June 2022
  1. PAREEK T, Parmar K, Sharma AP, Kumar S, et al
    Quality of Life, Efficacy, and Safety of Sequential Intravesical Gemcitabine + Docetaxel versus BCG for Non-Muscle Invasive Urinary Bladder Cancer: A Pilot Study.
    Urol Int. 2022 Jun 2:1-7. doi: 10.1159/000524098.
    PubMed     Abstract available


    February 2022
  2. KAMECKI H, Debowska M, Nyk L, Przewor A, et al
    The Clinical Features of Incidentally Diagnosed Urothelial Bladder Cancer: A Retrospective Data Analysis.
    Urol Int. 2022 Feb 11:1-8. doi: 10.1159/000521684.
    PubMed     Abstract available


  3. VOLZ Y, Pfitzinger PL, Eismann L, Ebner B, et al
    Prognostic Value of Pretreatment Inflammatory Markers in Patients Receiving Radical Cystectomy for Urothelial Bladder Cancer: Does Age Matter?
    Urol Int. 2022 Feb 8:1-8. doi: 10.1159/000521829.
    PubMed     Abstract available


  4. WEINHOLD P, Jokisch F, Schulz GB, Buchner A, et al
    Clinical Implication of Borderline CT-Morphological Metastatic Spread in Bladder Cancer: What You See Is Not Always What You Got.
    Urol Int. 2022 Feb 3:1-10. doi: 10.1159/000521857.
    PubMed     Abstract available


    January 2022
  5. LANNES F, Walz J, Maubon T, Rybikowski S, et al
    Enhanced Recovery after Surgery for Radical Cystectomy Decreases Postoperative Complications at Different Times.
    Urol Int. 2022;106:171-179.
    PubMed     Abstract available


  6. SHAO G, Xu C, Liu J, Li X, et al
    Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
    Urol Int. 2022;106:199-208.
    PubMed     Abstract available


  7. LIU Z, Zhang P, Wang H, Zheng B, et al
    Raman Spectrum-Based Diagnosis Strategy for Bladder Tumor.
    Urol Int. 2022;106:109-115.
    PubMed     Abstract available


  8. CHEN H, Wang M, Weng T, Wei Y, et al
    Prognostic Analysis of Diagnostic Ureteroscopic Biopsy for Intravesical Recurrence of Upper Urinary Tract Urothelial Carcinoma.
    Urol Int. 2022;106:186-194.
    PubMed     Abstract available


  9. ADAMCZYK P, Poblocki P, Kadlubowski M, Ostrowski A, et al
    Complication Rate after Radical Cystectomy Depends on the Surgical Technique and Patient's Clinical Status.
    Urol Int. 2022;106:163-170.
    PubMed     Abstract available


  10. LEE J, Suh J, Jeong CW, Kwak C, et al
    Efficacy of the Treatment of Intraperitoneal Bladder Perforation during Transurethral Resection of Bladder Tumor with the Urethral Catheter Alone: Retrospective Analysis of over 15 Years Using the Clinical Data Warehouse System.
    Urol Int. 2022;106:138-146.
    PubMed     Abstract available


  11. GROBET-JEANDIN E, Wirth GJ, Benamran D, Dupont A, et al
    Substaging of pT1 Urothelial Bladder Carcinoma Predicts Tumor Progression and Overall Survival.
    Urol Int. 2022;106:130-137.
    PubMed     Abstract available


  12. GRAFFEILLE V, Verhoest G, Gryn A, Kammerer-Jacquet SF, et al
    Complete Transurethral Resection before Radical Cystectomy May Improve Oncological Outcomes.
    Urol Int. 2022;106:122-129.
    PubMed     Abstract available


    December 2021
  13. ZAZZARA M, Nazaraj A, Scarcia M, Cardo G, et al
    Electromotive Drug Administration of Mitomycin C (EMDA/MMC) versus Intravesical Immunotherapy with Bacillus Calmette-Guerin (BCG) in Intermediate and High Risk Non Muscle Invasive Bladder Cancer.
    Urol Int. 2021 Dec 21:1-8. doi: 10.1159/000520630.
    PubMed     Abstract available


    November 2021
  14. PULLEN L, Kaspar C, Panic A, Hess J, et al
    Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer: A Retrospective Analysis of a Single-Centre Cohort.
    Urol Int. 2021 Nov 10:1-6. doi: 10.1159/000519898.
    PubMed     Abstract available


    October 2021
  15. WANG Y, Qu H, Xu B, Wu J, et al
    Expression of FOXA1 Is Associated with the Tumor-Infiltrating M2 Macrophage, Cytotoxic T Lymphocyte, and Effect of Chemotherapy in Bladder Cancer.
    Urol Int. 2021 Oct 27:1-6. doi: 10.1159/000519129.
    PubMed     Abstract available


  16. SU Q, Gao S, Lu C, Wu X, et al
    Comparing Prognosis Associated with Partial Cystectomy and Trimodal Therapy for Muscle-Invasive Bladder Cancer Patients.
    Urol Int. 2021 Oct 14:1-12. doi: 10.1159/000518562.
    PubMed     Abstract available


    August 2021
  17. STRUCK JP, Hennig MJP, Hupe MC, Moharam N, et al
    Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey.
    Urol Int. 2021 Aug 31:1-11. doi: 10.1159/000518166.
    PubMed     Abstract available


  18. RUCKHER J, Lobitz J, Follmann M, Derenz S, et al
    Guideline-Based Quality Indicators for Kidney and Bladder Cancer in Germany: Development and Implementation.
    Urol Int. 2021 Aug 12:1-8. doi: 10.1159/000517893.
    PubMed     Abstract available


  19. TOHI Y, Miyauchi Y, Yamasaki M, Fujiwara K, et al
    Incidental Bladder Cancer Found on Cystoscopy during Prostate Biopsy: Prevalence, Pathological Findings, and Oncological Outcome.
    Urol Int. 2021 Aug 5:1-7. doi: 10.1159/000517895.
    PubMed     Abstract available


  20. RAVENTOS BUSQUETS CX, Semidey ME, Lozano Palacio F, Carrion Puig A, et al
    Is Tumor Budding a New Predictor for Early Cystectomy in pT1 High-Grade Bladder Cancer?
    Urol Int. 2021 Aug 5:1-9. doi: 10.1159/000517543.
    PubMed     Abstract available


    June 2021
  21. GAO T, Ji Y
    Long Noncoding RNA LINC00707 Accelerates Tumorigenesis and Progression of Bladder Cancer via Targeting miR-145/CDCA3 Regulatory Loop.
    Urol Int. 2021 Jun 30:1-15. doi: 10.1159/000514388.
    PubMed     Abstract available


    March 2021
  22. CHEN P, Chen J, He L, Du C, et al
    Identification of circRNA-miRNA-mRNA Regulatory Network in Bladder Cancer by Integrated Analysis.
    Urol Int. 2021 Mar 31:1-11. doi: 10.1159/000512066.
    PubMed     Abstract available


  23. LIU Y, Huang X, Guo L, Luo N, et al
    LINC00649 Facilitates the Cellular Process of Bladder Cancer Cells via Signaling Axis miR-16-5p/JARID2.
    Urol Int. 2021 Mar 31:1-9. doi: 10.1159/000506239.
    PubMed     Abstract available


  24. LIU Z, Zhang Y, Sun G, Ouyang W, et al
    Comparison of Thulium Laser Resection of Bladder Tumors and Conventional Transurethral Resection of Bladder Tumors for Non-Muscle-Invasive Bladder Cancer.
    Urol Int. 2021 Mar 30:1-6. doi: 10.1159/000514042.
    PubMed     Abstract available


    February 2021
  25. YANG X, Zhuang J, Yu H, Cao Q, et al
    Effect of Coronavirus Disease 2019 on Patients with Bladder Cancer in China.
    Urol Int. 2021 Feb 24:1-3. doi: 10.1159/000512895.
    PubMed    


    January 2021
  26. KAYNAR M, Celik ZE, Altintas E, Batur AF, et al
    Comparison of Two Different Bipolar Energy Resources in Transurethral Resection of Bladder Tumors.
    Urol Int. 2021;105.
    PubMed     Abstract available


  27. IZOL V, Deger M, Ozden E, Bolat D, et al
    The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.
    Urol Int. 2021;105.
    PubMed     Abstract available


  28. YANG C, Lv Z, Li Y
    Reduction of Bladder Volume after BCG Immunotherapy.
    Urol Int. 2021;105.
    PubMed     Abstract available


    December 2020
  29. RABER M, Buchholz N, Vercesi A, Hendawi NA, et al
    Treatment of Large Non-Muscle-Invasive Bladder Cancer: The Potential Role of Neoadjuvant Intravesical Chemotherapy.
    Urol Int. 2020 Dec 17:1-6. doi: 10.1159/000512052.
    PubMed     Abstract available


    August 2020
  30. MAISCH P, Retz M, Gschwend JE, Koll F, et al
    Clinical Practice Guidelines for Bladder Cancer: A Systematic Review and Meta-Analysis Using the AGREE II Instrument.
    Urol Int. 2020 Aug 21:1-10. doi: 10.1159/000509431.
    PubMed     Abstract available


    July 2020
  31. CHEN G, Yang T, Shao Q, Zhang M, et al
    Sub-Staging-Specific Differences in Recurrence-Free, Progression-Free, and Cancer-Specific Survival for Patients with T1 Bladder Cancer: A Systematic Review and Meta-Analysis.
    Urol Int. 2020 Jul 1:1-7. doi: 10.1159/000506238.
    PubMed     Abstract available


    June 2020
  32. WU J, Wang YC, Luo WJ, Dai B, et al
    Diagnostic Performance of Confocal Laser Endomicroscopy for the Detection of Bladder Cancer: Systematic Review and Meta-Analysis.
    Urol Int. 2020 Jun 18:1-10. doi: 10.1159/000508417.
    PubMed     Abstract available


  33. NAKANE K, Enomoto T, Hishida S, Tomioka M, et al
    The Utility and Efficacy of Laparoscopic Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer at a Single Institution.
    Urol Int. 2020 Jun 17:1-7. doi: 10.1159/000508192.
    PubMed     Abstract available


  34. BUSETTO GM, Porreca A, Del Giudice F, Maggi M, et al
    SARS-CoV-2 Infection and High-Risk Non-Muscle-Invasive Bladder Cancer: Are There Any Common Features?
    Urol Int. 2020 Jun 9:1-13. doi: 10.1159/000509065.
    PubMed     Abstract available


    May 2020
  35. XU J, Wang C, Ouyang J, Sun J, et al
    Efficacy and Safety of Transurethral Laser Surgery Versus Transurethral Resection for Non-Muscle-Invasive Bladder Cancer: A Meta-Analysis and Systematic Review.
    Urol Int. 2020 May 27:1-14. doi: 10.1159/000506655.
    PubMed     Abstract available


  36. SERRETTA V, Di Maida F, Baiamonte D, Vella M, et al
    Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study.
    Urol Int. 2020 May 5:1-6. doi: 10.1159/000507122.
    PubMed     Abstract available


    March 2020
  37. SUAREZ-IBARROLA R, Hein S, Farin E, Waldbillig F, et al
    Current Standards in the Endoscopic Management of Bladder Cancer: A Survey Evaluation among Urologists in German-Speaking Countries.
    Urol Int. 2020 Mar 25:1-7. doi: 10.1159/000506653.
    PubMed     Abstract available


    January 2020
  38. YANG H, Lin J, Gao P, He Z, et al
    Is the En Bloc Transurethral Resection More Effective than Conventional Transurethral Resection for Non-Muscle-Invasive Bladder Cancer? A Systematic Review and Meta-Analysis.
    Urol Int. 2020 Jan 7:1-8. doi: 10.1159/000503734.
    PubMed     Abstract available


  39. SUZUKI K, Hinata N, Inoue TA, Nakamura I, et al
    Comparison of the Perioperative and Postoperative Outcomes of Ileal Conduit and Cutaneous Ureterostomy: A Propensity Score-Matched Analysis.
    Urol Int. 2020;104.
    PubMed     Abstract available


  40. POLETAJEW S, Krajewski W, Adamowicz J, Kolodziej A, et al
    Management of Intradiverticular Bladder Tumours: A Systematic Review.
    Urol Int. 2020;104.
    PubMed     Abstract available


  41. JOKISCH JF, Grimm T, Buchner A, Kretschmer A, et al
    Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome.
    Urol Int. 2020;104.
    PubMed     Abstract available


  42. ZHU C, Deng Z, Yuan L, Su J, et al
    Transurethral-Assisted Transumbilical Laparoendoscopic Single-Site Radical Cystectomy: Initial Short-Term Experience.
    Urol Int. 2020;104.
    PubMed     Abstract available


  43. SARIER M, Sepin N, Keles Y, Imir L, et al
    Is There any Association between Urothelial Carcinoma of the Bladder and Human Papillomavirus? A Case-Control Study.
    Urol Int. 2020;104.
    PubMed     Abstract available


  44. FROEHNER M, Koch R, Heberling U, Borkowetz A, et al
    Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical Cystectomy.
    Urol Int. 2020;104.
    PubMed     Abstract available


  45. FEDELI U, De Paoli A, Corti MC, Cacciamani GE, et al
    Perioperative Mortality and Long-Term Survival after Radical Cystectomy: A Population-Based Study in a Southern European Country on 4,389 Patients.
    Urol Int. 2020;104.
    PubMed     Abstract available


  46. TAMALUNAS A, Buchner A, Kretschmer A, Jokisch F, et al
    Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.
    Urol Int. 2020;104.
    PubMed     Abstract available


    December 2019
  47. ZIEGELMUELLER BK, Jokisch JF, Buchner A, Grimm T, et al
    Long-Term Follow-Up and Oncological Outcome of Patients Undergoing Radical Cystectomy for Bladder Cancer following an Enhanced Recovery after Surgery (ERAS) Protocol: Results of a Large Randomized, Prospective, Single-Center Study.
    Urol Int. 2019 Dec 4:1-7. doi: 10.1159/000504236.
    PubMed     Abstract available


    October 2019
  48. FROEHNER M, Muallah D, Koch R, Hubler M, et al
    Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical Cystectomy.
    Urol Int. 2019 Oct 22:1-8. doi: 10.1159/000502781.
    PubMed     Abstract available


    September 2019
  49. HAUTMANN RE, Bolenz C, Volkmer B
    Unexpected Early Oncologic Mortality after Open Radical Cystectomy for Bladder Cancer: Who Is to Be Blamed?
    Urol Int. 2019 Sep 27:1-6. doi: 10.1159/000503398.
    PubMed     Abstract available


    January 2019
  50. SHIGEMURA K, Tanaka K, Hamasuna R, Ishikawa K, et al
    Efficacy of Prophylactic Antimicrobial Administration of Tazobactam/Piperacillin for Radical Cystectomy with Urinary Diversion: A Multicenter Study.
    Urol Int. 2019;102:293-298.
    PubMed     Abstract available


  51. URBINA-LIMA AD, Roman-Martin AA, Crespo-Santos A, Martinez-Rodriguez A, et al
    Solitary Fibrous Tumor of the Urinary Bladder Associated with Hypoglycemia: An Unusual Case of Doege-Potter Syndrome.
    Urol Int. 2019;103:120-124.
    PubMed     Abstract available


  52. SCHULZ GB, Grimm T, Buchner A, Kretschmer A, et al
    Benefits and Complications during the Stay at an Early Rehabilitation Facility after Radical Cystectomy and Orthotopic Ileum Neobladder Reconstruction.
    Urol Int. 2019;103:350-356.
    PubMed     Abstract available


  53. AZNAR MARTINEZ L, Lopez Cubillana P, Lopez Abad A, Vidal Crespo N, et al
    Bacillus Calmette-Guerin in Immunosuppressed Patient with High-Grade Nonmuscle Invasive Bladder Carcinoma.
    Urol Int. 2019;103:242-244.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: